Analysts Set DocGo Inc. (NASDAQ:DCGO) PT at $2.38

Shares of DocGo Inc. (NASDAQ:DCGOGet Free Report) have earned an average rating of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $2.3750.

Several equities research analysts have weighed in on DCGO shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $3.00 target price on shares of DocGo in a research report on Tuesday, March 17th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. Stifel Nicolaus dropped their target price on DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research report on Tuesday, March 17th. Canaccord Genuity Group dropped their target price on DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Wednesday, March 25th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $3.00 target price on shares of DocGo in a research report on Tuesday, March 17th.

View Our Latest Analysis on DocGo

DocGo Price Performance

Shares of NASDAQ DCGO opened at $0.57 on Friday. DocGo has a 1-year low of $0.55 and a 1-year high of $2.65. The business’s fifty day moving average price is $0.70 and its two-hundred day moving average price is $0.93. The firm has a market capitalization of $56.29 million, a PE ratio of -0.31 and a beta of 0.98.

Institutional Investors Weigh In On DocGo

Large investors have recently added to or reduced their stakes in the stock. AQR Capital Management LLC increased its holdings in shares of DocGo by 219.1% during the first quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock valued at $1,258,000 after purchasing an additional 327,269 shares during the period. Jane Street Group LLC increased its holdings in shares of DocGo by 18.8% during the first quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock valued at $226,000 after purchasing an additional 13,505 shares during the period. Acadian Asset Management LLC acquired a new position in shares of DocGo during the first quarter valued at $338,000. Strs Ohio acquired a new position in shares of DocGo during the first quarter valued at $76,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of DocGo by 16.8% during the second quarter. JPMorgan Chase & Co. now owns 290,354 shares of the company’s stock valued at $456,000 after purchasing an additional 41,679 shares during the period. 56.44% of the stock is owned by institutional investors and hedge funds.

DocGo Company Profile

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Further Reading

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.